Ignite Creation Date:
2025-12-24 @ 2:53 PM
Ignite Modification Date:
2026-01-27 @ 5:11 AM
Study NCT ID:
NCT03335059
Status:
TERMINATED
Last Update Posted:
2020-04-15
First Post:
2017-10-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Mitomycin C Intravesical Chemotherapy in Conjunction With Synergo® Radiofrequency-Induced Hyperthermia for Treatment of Carcinoma in Situ Non-Muscle Invasive Bladder Cancer Patients Unresponsive to Bacillus Calmette-Guérin, With or Without Papillary Tumors.
Sponsor:
Medical Enterprises Ltd.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Bladder Cancer | View |
| None | Bladder Neoplasm | View |
| None | Bladder Tumors | View |
| None | Cancer of Bladder | View |
| None | Cancer of the Bladder | View |
| None | Malignant Tumor of Urinary Bladder | View |
| None | Neoplasms, Bladder | View |
| None | Urinary Bladder Cancer | View |
| None | Carcinoma in Situ of Bladder | View |
| None | Papillary Carcinoma of Bladder (Diagnosis) | View |
| None | BCG-Unresponsive Bladder Cancer | View |